The Canadian Agency for Drugs and Technologies in Health, or CADTH, is a Canadian national organisation that provides research and analysis to healthcare decision-makers.[1]

The organisation was established in 1989 by the country's federal government, and those of its provinces and territories.[2] Before April 2006, CADTH was known as the Canadian Coordinating Office for Health Technology Assessment (CCOHTA).[3][4]

On December 18th, 2023, The Government of Canada announced that CADTH would be superseded by the Canadian Drug Agency (CDA).[5]

Canadian Drug Agency Transition Office and Canadian Drug Agency

In 2021, The Government of Canada established The Canadian Drug Agency Transition Office or CDATO in order to move forward with promises of a National Pharmacare program announced in the 2019 Federal Budget.[6][7]

The responsibility of the CDATO was to "work with provinces, territories and key stakeholders on a vision, mandate and plan to establish a [Canadian Drug Agency] that will improve pharmaceutical system coordination and support related work." [6]

The CDATO found various shortcomings within Canada's existing pharmaceutical system, including but not limited to: fragmentation, inadequate infrastructure and poor return on investment as well as duplication of resources. [6]

On December 18th 2023, The Government of Canada announced that CDATO and CADTH would be superseded by the Canadian Drug Agency (CDA), with $89.5 million over the next five years dedicated to establishing the CDA.[5] The CDA's mandate will build upon CADTH's existing mandate and functionality, while expanding upon it using the recommendations provided the CDATO.[5]

See also

References

  1. ↑ Rich, Pat (7 May 2018). "Low awareness about CADTH among practising doctors in Canada". Canadian Medical Association Journal. 190 (18): E576. doi:10.1503/cmaj.109-5595. ISSN 1488-2329. PMC 5940463. PMID 29735539.
  2. ↑ "About CADTH". CADTH. Retrieved 6 October 2017.
  3. ↑ "CADTH History". CADTH. Retrieved 6 October 2017.
  4. ↑ "Pharmaceutical HTA and Reimbursement Processes – Canada". ispor.org. Archived from the original on 22 July 2018. Retrieved 22 July 2018.
  5. 1 2 3 Canada, Health (18 December 2023). "The Government of Canada announces the creation of the Canadian Drug Agency". www.canada.ca. Retrieved 3 January 2024.
  6. 1 2 3 "Canadian Drug Agency Transition Office". www.canada.ca. 21 February 2023. Retrieved 3 January 2024.
  7. ↑ Government of Canada, Department of Finance (19 March 2019). "Budget 2019: Home". www.budget.canada.ca. Retrieved 3 January 2024.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.